Señales en vivo de YS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (21 may 2024 @ 15:59):

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer...

Stats
Volumen de hoy	52 626.00
Volumen promedio	176 429
Capitalización de mercado	184.56M
EPS	$0 ( 2024-04-19 )
Próxima fecha de ganancias	( $-0.0900 ) 2024-08-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.720
ATR14	$0.00500 (0.51%)

Volumen Correlación

Largo: -0.24 (neutral)

Corto: 0.31 (neutral)

Signal:(51.931) Neutral

YS Biopharma Co., Ltd. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

YS Biopharma Co., Ltd. Correlación - Moneda/Commodity

-0.06
( neutral )

-0.02
( neutral )

0.00
( neutral )

0.02
( neutral )

YS Biopharma Co., Ltd. Finanzas

Annual	2023
Ingresos:	$687.20M
Beneficio Bruto:	$533.84M (77.68 %)
EPS:	$-1.560

FY	2023
Ingresos:	$687.20M
Beneficio Bruto:	$533.84M (77.68 %)
EPS:	$-1.560

FY	2022
Ingresos:	$502.95M
Beneficio Bruto:	$385.88M (76.72 %)
EPS:	$-1.150

Financial Reports:

No articles found.

YS Biopharma Co., Ltd. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

YS Biopharma Co., Ltd.

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.